1. Ou, S. H., Wu, F., Harrich, D., Garcia-Martinez, L. F. & Gaynor, R. B. Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs. J. Virol. 69, 3584-3596, https://doi.org/10.1128/JVI.69.6.3584-3596.1995 (1995).
2. Tziortzouda, P., Van Den Bosch, L. & Hirth, F. Triad of TDP43 control in neurodegeneration: autoregulation, localization and aggregation. Nat. Rev. Neurosci. 22, 197-208, https://doi.org/10.1038/s41583-021-00431-1 (2021).
3. Buratti, E. et al. Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J. 20, 1774-1784, https://doi.org/10.1093/emboj/20.7.1774 (2001).
4. Wu, L. S. et al. TDP-43, a neuro-pathosignature factor, is essential for early mouse embryogenesis. Genesis 48, 56-62, https://doi.org/10.1002/dvg.20584 (2010).
5. Sephton, C. F. et al. TDP-43 is a developmentally regulated protein essential for early embryonic development. J. Biol. Chem. 285, 6826-6834, https://doi.org/10.1074/jbc.M109.061846 (2010).
6. Kraemer, B. C. et al. Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis. Acta Neuropathol. 119, 409-419, https://doi.org/10.1007/s00401-010-0659-0 (2010).
7. Neumann, M. et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314, 130-133, https://doi.org/10.1126/science.1134108 (2006).
8. Arai, T. et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 351, 602-611, https://doi.org/10.1016/j.bbrc.2006.10.093 (2006).
9. Ayala, Y. M. et al. TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J. 30, 277-288, https://doi.org/10.1038/emboj.2010.310 (2011).
10. Polymenidou, M. et al. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat. Neurosci. 14, 459-468, https://doi.org/10.1038/nn.2779 (2011).
11. Avendano-Vazquez, S. E. et al. Autoregulation of TDP-43 mRNA levels involves interplay between transcription, splicing, and alternative polyA site selection. Genes Dev. 26, 1679-1684, https://doi.org/10.1101/gad.194829.112 (2012).
12. Bembich, S. et al. Predominance of spliceosomal complex formation over polyadenylation site selection in TDP-43 autoregulation. Nucleic Acids Res. 42, 3362-3371, https://doi.org/10.1093/nar/gkt1343 (2014).
13. Koyama, A. et al. Increased cytoplasmic TARDBP mRNA in affected spinal motor neurons in ALS caused by abnormal autoregulation of TDP-43. Nucleic Acids Res. 44, 5820-5836, https://doi.org/10.1093/nar/gkw499 (2016).
14. Sugai, A. et al. Robustness and vulnerability of the autoregulatory system that maintains nuclear TDP-43 levels: a trade-off hypothesis for ALS pathology based on in silico data. Front. Neurosci. 12, 28, https://doi.org/10.3389/fnins.2018.00028 (2018).
15. Sugai, A. et al. Non-genetically modified models exhibit TARDBP mRNA increase due to perturbed TDP-43 autoregulation. Neurobiol. Dis. 130, 104534, https://doi.org/10.1016/j.nbd.2019.104534 (2019).
16. Jiang, L. L. et al. Structural transformation of the amyloidogenic core region of TDP-43 protein initiates its aggregation and cytoplasmic inclusion. J. Biol. Chem. 288, 19614-19624, https://doi.org/10.1074/jbc.M113.463828 (2013).
17. Mompean, M., Baralle, M., Buratti, E. & Laurents, D. V. An amyloid-like pathological conformation of TDP-43 is stabilized by hypercooperative hydrogen bonds. Front. Mol. Neurosci. 9, 125, https://doi.org/10.3389/fnmol.2016.00125 (2016).
18. Hasegawa, M. et al. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann. Neurol. 64, 60-70, https://doi.org/10.1002/ana.21425 (2008).
19. Neumann, M. et al. Phosphorylation of S409/410 of TDP-43 is a consistent feature in all sporadic and familial forms of TDP-43 proteinopathies. Acta Neuropathol. 117, 137-149, https://doi.org/10.1007/s00401-008-0477-9 (2009).
20. Nonaka, T. et al. Phosphorylation of TAR DNA-binding protein of 43 kDa (TDP-43) by truncated casein kinase 1δ triggers mislocalization and accumulation of TDP-43. J. Biol. Chem. 291, 5473-5483, https://doi.org/10.1074/jbc.M115.695379 (2016).
21. Nishino, K. et al. Mice deficient in the C-terminal domain of TAR DNA-binding protein 43 develop age-dependent motor dysfunction associated with impaired Notch1-Akt signaling pathway. Acta Neuropathol. Commun. 7, 118, https://doi.org/10.1186/s40478-019-0776-5 (2019).
22. Winton, M. J. et al. Disturbance of nuclear and cytoplasmic TAR DNA-binding protein (TDP-43) induces disease-like redistribution, sequestration, and aggregate formation. J. Biol. Chem. 283, 13302-13309, https://doi.org/10.1074/jbc.M800342200 (2008).
23. Ayala, Y. M. et al. Structural determinants of the cellular localization and shuttling of TDP-43. J. Cell Sci. 121, 3778-3785, https://doi.org/10.1242/jcs.038950 (2008).
24. Nonaka, T., Kametani, F., Arai, T., Akiyama, H. & Hasegawa, M. Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43. Hum. Mol. Genet. 18, 3353-3364, https://doi.org/10.1093/hmg/ddp275 (2009).
25. Wang, H. Y., Wang, I. F., Bose, J. & Shen, C. K. Structural diversity and functional implications of the eukaryotic TDP gene family. Genomics 83, 130-139, https://doi.org/10.1016/s0888-7543(03)00214-3 (2004).
26. Schmidt, H. B., Barreau, A. & Rohatgi, R. Phase separation-deficient TDP43 remains functional in splicing. Nat. Commun. 10, 4890, https://doi.org/10.1038/s41467-019-12740-2 (2019).
27. Kato, M. et al. Cell-free formation of RNA granules: low complexity sequence domains form dynamic fibers within hydrogels. Cell 149, 753-767, https://doi.org/10.1016/j.cell.2012.04.017 (2012).
28. Conicella, A. E., Zerze, G. H., Mittal, J. & Fawzi, N. L. ALS mutations disrupt phase separation mediated by α-helical structure in the TDP-43 low-complexity C-terminal domain. Structure 24, 1537-1549, https://doi.org/10.1016/j.str.2016.07.007 (2016).
29. Conicella, A. E. et al. TDP-43 α-helical structure tunes liquid-liquid phase separation and function. Proc. Natl. Acad. Sci. U. S. A. 117, 5883-5894, https://doi.org/10.1073/pnas.1912055117 (2020).
30. Guenther, E. L. et al. Atomic structures of TDP-43 LCD segments and insights into reversible or pathogenic aggregation. Nat. Struct. Mol. Biol. 25, 463-471, https://doi.org/10.1038/s41594-018-0064-2 (2018).
31. Loughlin, F. E. & Wilce, J. A. TDP-43 and FUS-structural insights into RNA recognition and self-association. Curr. Opin. Struct. Biol. 59, 134-142, https://doi.org/10.1016/j.sbi.2019.07.012 (2019).
32. Shenoy, J. et al. Structural dissection of amyloid aggregates of TDP-43 and its C-terminal fragments TDP-35 and TDP-16. FEBS J. 287, 2449-2467, https://doi.org/10.1111/febs.15159 (2020).
33. D'Ambrogio, A. et al. Functional mapping of the interaction between TDP-43 and hnRNP A2 in vivo. Nucleic Acids Res. 37, 4116-4126, https://doi.org/10.1093/nar/gkp342 (2009).
34. Daoud, H. et al. Contribution of TARDBP mutations to sporadic amyotrophic lateral sclerosis. J. Med. Genet. 46, 112-114, https://doi.org/10.1136/jmg.2008.062463 (2009).
35. Darling, A. L. & Uversky, V. N. Intrinsic disorder and posttranslational modifications: the darker side of the biological dark matter. Front. Genet. 9, 158, https://doi.org/10.3389/fgene.2018.00158 (2018).
36. Gasset-Rosa, F. et al. Cytoplasmic TDP-43 de-mixing independent of stress granules drives inhibition of nuclear import, loss of nuclear TDP-43, and cell death. Neuron 102, 339-357, https://doi.org/10.1016/j.neuron.2019.02.038 (2019).
37. Yu, H. et al. HSP70 chaperones RNA-free TDP-43 into anisotropic intranuclear liquid spherical shells. Science 371, eabb4309, https://doi.org/10.1126/science.abb4309 (2021).
38. Pinarbasi, E. S. et al. Active nuclear import and passive nuclear export are the primary determinants of TDP-43 localization. Sci. Rep. 8, 7083, https://doi.org/10.1038/s41598-018-25008-4 (2018).
39. Ederle, H. et al. Nuclear egress of TDP-43 and FUS occurs independently of Exportin-1/CRM1. Sci. Rep. 8, 7084, https://doi.org/10.1038/s41598-018-25007-5 (2018).
40. Hashimoto, M. & Takemoto, T. Electroporation enables the efficient mRNA delivery into the mouse zygotes and facilitates CRISPR/Cas9-based genome editing. Sci. Rep. 5, 11315, https://doi.org/10.1038/srep11315 (2015).
41. Itakura, M., Tsujimura, J., Yamamori, S., Ohkido, T. & Takahashi, M. NMDA receptor-dependent recruitment of calnexin to the neuronal plasma membrane. Neurosci. Lett. 550, 173-178, https://doi.org/10.1016/j.neulet.2013.06.064 (2013).
42. Yamamori, S. et al. Differential expression of SNAP-25 family proteins in the mouse brain. J. Comp. Neurol. 519, 916-932, https://doi.org/10.1002/cne.22558 (2011).
43. Yokoseki, A. et al. TDP-43 mutation in familial amyotrophic lateral sclerosis. Ann. Neurol. 63, 538-542, https://doi.org/10.1002/ana.21392 (2008).